+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Rx/Reimbursement Adult Incontinence in Russia

  • PDF Icon

    Report

  • 21 Pages
  • June 2020
  • Region: Russia
  • Euromonitor International
  • ID: 4517591
Rx/reimbursement adult incontinence demonstrated a stronger growth trend than retail adult incontinence in Russia in 2019, with slow current value growth compared with strong current value decline. This was the same trend as seen in 2018. Although after an enormous increase in 2016 the growth rate slowed during the review period, the programme is still financed from the state budget and is popular amongst consumers facing decreasing purchasing power.

The Rx/Reimbursement adult incontinence in Russia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Total Adult Incontinence.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

List of Contents and TablesHEADLINES
PRE-COVID-19 PERFORMANCE
  • Continued although slower growth for a popular programme
  • Hoops to jump through to access funding

2020 AND BEYOND
  • COVID-19 impact
  • Recovery and opportunities

CATEGORY DATA
Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2014-2019
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2014-2019
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2019-2024
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2019-2024
EXECUTIVE SUMMARY
  • COVID-19 impact on tissue and hygiene
  • COVID-19 country impact
  • Economic woes hamper spending by price-sensitive consumers and the state
  • Local players and private label challenge the international leaders
  • Return to normal purchasing patterns to be quicker in the retail than the AFH channel
Chart 1 Tissue and Hygiene Value Sales Growth Scenarios: 2017-2024
Chart 2 issue and Hygiene Impact of Soft Drivers on Value Sales: 2016-2024
MARKET INDICATORS
Table 5 Birth Rates 2014-2019
Table 6 Infant Population 2014-2019
Table 7 Female Population by Age 2014-2019
Table 8 Total Population by Age 2014-2019
Table 9 Households 2014-2019
Table 10 Forecast Infant Population 2019-2024
Table 11 Forecast Female Population by Age 2019-2024
Table 12 Forecast Total Population by Age 2019-2024
Table 13 Forecast Households 2019-2024
MARKET DATA
Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2014-2019
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2014-2019
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2015-2019
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2016-2019
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2014-2019
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2014-2019
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2019
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2019-2024
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2019-2024
GLOBAL MACROECONOMIC ENVIRONMENTGLOBAL INDUSTRY ENVIRONMENTDISCLAIMER
SOURCES
Summary 1 Research Sources